THREE-YEAR RESULTS FROM THE EVOLVE II RANDOMIZED TRIAL: LATE CLINICAL OUTCOMES WITH BIORESORBABLE COMPARED TO PERMANENT POLYMER EVEROLIMUS-ELUTING

被引：1
|
作者：
Kereiakes, Dean J. [1 ]
Meredith, Ian [1 ]
Windecker, Stephan [1 ]
Rodes-Cabau, Josep [1 ]
Lee, Tommy [1 ]
Reitman, Arthur [1 ]
Erglis, Andrejs [1 ]
Dorogy, Mark [1 ]
Bertolet, Barry [1 ]
Cannon, Louis [1 ]
Airaksinen, Juhani [1 ]
Siegel, Craig [1 ]
Christen, Thomas [1 ]
Allocco, Dominic [1 ]
Dawkins, Keith [1 ]
机构：
[1] Christ Hosp, Heart & Vasc Ctr, Lindner Res Ctr, Cincinnati, OH 45219 USA
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2017年 / 69卷 / 11期
关键词：
D O I：
10.1016/S0735-1097(17)34359-0
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1135M-09
引用
收藏
页码：970 / 970
页数：1
相关论文
共 50 条
  • [41] Three-Year Clinical Outcomes of Everolimus-Eluting Stents From the Post-Marketing Surveillance Study of Cobalt-Chromium Everolimus-Eluting Stent (XIENCE V/PROMUS) in Japan
    Aoki, Jiro
    Kozuma, Ken
    Awata, Masaki
    Nanasato, Mamoru
    Shiode, Nobuo
    Tanabe, Kengo
    Yamaguchi, Junichi
    Kusano, Hajime
    Nie, Hong
    Kimura, Takeshi
    CIRCULATION JOURNAL, 2016, 80 (04) : 906 - +
  • [42] Three-year clinical outcomes of the absorb bioresorbable vascular scaffold compared to Xience everolimus-eluting stent in routine PCI in patients with diabetes mellitus-AIDA sub-study
    Kerkmeijer, Laura S. M.
    Tijssen, Ruben Y. G.
    Hofma, Sjoerd H.
    van Der Schaaf, Rene J.
    Arkenbout, E. Karin
    Weevers, Auke P. J. D.
    Kraak, Robin P.
    Onuma, Yoshinobu
    Serruys, Patrick W.
    Piek, Jan J.
    Tijssen, Jan G. P.
    Henriques, Jose P. S.
    de Winter, Robbert J.
    Wykrzykowska, Joanna J.
    CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2021, 98 (04) : 713 - 720
  • [43] Primary Endpoint Results of the EVOLVE Trial A Randomized Evaluation of a Novel Bioabsorbable Polymer-Coated, Everolimus-Eluting Coronary Stent
    Meredith, Ian T.
    Verheye, Stefan
    Dubois, Christophe L.
    Dens, Joseph
    Fajadet, Jean
    Carrie, Didier
    Walsh, Simon
    Oldroyd, Keith G.
    Varenne, Olivier
    El-Jack, Seif
    Moreno, Raul
    Joshi, Anita A.
    Allocco, Dominic J.
    Dawkins, Keith D.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2012, 59 (15) : 1362 - 1370
  • [44] Long-term clinical outcomes of biodegradable polymer biolimus-eluting stents versus durable polymer everolimus-eluting stents in patients with coronary artery disease: three-year follow-up of the COMPARE II (Abluminal biodegradable polymer biolimus-eluting stent versus durable polymer everolimus-eluting stent) trial
    Vlachojannis, Georgios J.
    Smits, Pieter C.
    Hofma, Sjoerd H.
    Togni, Mario
    Vazquez, Nicolas
    Valdes, Mariano
    Voudris, Vassilis
    Puricel, Serban
    Slagboom, Ton
    Goy, Jean-Jacques
    den Heijer, Peter
    van der Ent, Martin
    EUROINTERVENTION, 2015, 11 (03) : 272 - 279
  • [45] Mid-term clinical outcomes of biodegradable polymer everolimus-eluting stents compared with durable polymer everolimus-eluting stents: a propensity-matched study
    Matsuda, H.
    Kagase, A.
    Tokuda, T.
    Ochiumi, Y.
    Takeya, M.
    Sato, K.
    Murata, A.
    Suzuki, Y.
    Ito, T.
    EUROPEAN HEART JOURNAL, 2020, 41 : 97 - 97
  • [46] Comparison of long-term clinical outcomes in multivessel coronary artery disease patients treated either with bioresoarbable polymer sirolimus-eluting stent or permanent polymer everolimus-eluting stent: 5-year results of the CENTURY II randomized clinical trial
    Iniguez, Andres
    Chevalier, Bernard
    Richardt, Gert
    Neylon, Antoinette
    Jimenez, Victor A.
    Kornowski, Ran
    Carrie, Didier
    Moreno, Raul
    Barbato, Emanuele
    Serra-Penaranda, Antoni
    Guiducci, Vincenzo
    Valdes-Chavarri, Mariano
    Yajima, Junji
    Wijns, William
    Saito, Shigeru
    CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2020, 95 (02) : 175 - 184
  • [47] Ultrathin Bioresorbable-Polymer Sirolimus-Eluting Stents Versus Thin Durable -Polymer Everolimus-Eluting Stents for Coronary Revascularization 3-Year Outcomes From the Randomized BIOFLOW V Trial
    Kandzari, David E.
    Koolen, Jacques J.
    Doros, Gheorghe
    Garcia-Garcia, Hector M.
    Bennett, Johan
    Roguin, Ariel
    Gharib, Elie G.
    Cutlip, Donald E.
    Waksman, Ron
    JACC-CARDIOVASCULAR INTERVENTIONS, 2020, 13 (11) : 1343 - 1353
  • [48] 1-Year Clinical Outcomes of Diabetic Patients Treated With Everolimus-Eluting Bioresorbable Vascular Scaffolds
    Muramatsu, Takashi
    Onuma, Yoshinobu
    van Geuns, Robert-Jan
    Chevalier, Bernard
    Patel, Tejas M.
    Seth, Ashok
    Diletti, Roberto
    Garcia-Garcia, Hector M.
    Dorange, Cecile C.
    Veldhof, Susan
    Cheong, Wai-Fung
    Ozaki, Yukio
    Whitbourn, Robert
    Bartorelli, Antonio
    Stone, Gregg W.
    Abizaid, Alexandre
    Serruys, Patrick W.
    JACC-CARDIOVASCULAR INTERVENTIONS, 2014, 7 (05) : 482 - 493
  • [49] Abluminal groove-filled biodegradable polymer sirolimus-eluting stent versus durable polymer everolimus-eluting stent: three-year results of the TARGET All Comers trial
    Saito, Yuichi
    Kelbaek, Henning
    Xu, Bo
    Hussain, Yasin
    Anderson, Richard
    Schaechinger, Volker
    Zheng, Ming
    Wijns, William
    Baumbach, Andreas
    Lansky, Alexandra
    EUROINTERVENTION, 2021, 17 (04) : E332 - +
  • [50] Treatment of in-stent-restenosis with everolimus-eluting bioresorbable scaffolds - The 5-year results of the randomized ABSORB-ISR trial
    Bossard, Matthias
    Madanchi, Mehdi
    Attinger-Toller, Adrian
    Cioffi, Giacomo Maria
    Seiler, Thomas
    Majcen, Irena
    Zhi, Yuan
    Gjergjizi, Varis
    Toggweiler, Stefan
    Cuculi, Florim
    SWISS MEDICAL WEEKLY, 2023, 153 : 124S - 125S
12345